Overview

Duloxetine in the Treatment of Stress Urinary Incontinence.

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride
Criteria
Inclusion Criteria:

- Women with predominant stress urinary incontinence.

- 7 or more incontinence episodes per week.

Exclusion Criteria:

- Use of monoamine inhibitors.